These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. In vivo evaluation in rodents of [(123)I]-3-I-CO as a potential SPECT tracer for the serotonin 5-HT(2A) receptor. Blanckaert PB, Burvenich I, Wyffels L, De Bruyne S, Moerman L, De Vos F. Nucl Med Biol; 2008 Nov; 35(8):861-7. PubMed ID: 19026947 [Abstract] [Full Text] [Related]
7. [11C]AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain. Pierson ME, Andersson J, Nyberg S, McCarthy DJ, Finnema SJ, Varnäs K, Takano A, Karlsson P, Gulyás B, Medd AM, Lee CM, Powell ME, Heys JR, Potts W, Seneca N, Mrzljak L, Farde L, Halldin C. Neuroimage; 2008 Jul 01; 41(3):1075-85. PubMed ID: 18434202 [Abstract] [Full Text] [Related]
8. Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor: structurally specific differentiation by ergolines and tryptamines. Nelson DL, Lucaites VL, Audia JE, Nissen JS, Wainscott DB. J Pharmacol Exp Ther; 1993 Jun 01; 265(3):1272-9. PubMed ID: 8510008 [Abstract] [Full Text] [Related]
11. In vivo binding of [3H]ketanserin on serotonin S2-receptors in rat brain. Laduron PM, Janssen PF, Leysen JE. Eur J Pharmacol; 1982 Jun 16; 81(1):43-8. PubMed ID: 7117369 [Abstract] [Full Text] [Related]
13. Hypothermia reduces the rate of dissociation of specific ligands from dopamine-D2 and 5-hydroxytryptamine1A receptors in the mouse brain in vivo. Stenfors C, Ross SB. Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov 16; 364(5):479-86. PubMed ID: 11692232 [Abstract] [Full Text] [Related]
14. In vivo quantification of cerebral muscarinic receptors in normal human aging using positron emission tomography and [11C]tropanyl benzilate. Lee KS, Frey KA, Koeppe RA, Buck A, Mulholland GK, Kuhl DE. J Cereb Blood Flow Metab; 1996 Mar 16; 16(2):303-10. PubMed ID: 8594063 [Abstract] [Full Text] [Related]
15. Preliminary studies of human cortical 5-HT2 receptors and their involvement in schizophrenia and neuroleptic drug action. Reynolds GP, Rossor MN, Iversen LL. J Neural Transm Suppl; 1983 Mar 16; 18():273-7. PubMed ID: 6135746 [Abstract] [Full Text] [Related]
16. Differential serotonin2 receptor recovery in mature and senescent rat brain after irreversible receptor modification: effect of chronic reserpine treatment. Battaglia G, Norman AB, Creese I. J Pharmacol Exp Ther; 1987 Oct 16; 243(1):69-75. PubMed ID: 2889827 [Abstract] [Full Text] [Related]
17. [3H]ketanserin labels 5-HT2 receptors and alpha 1-adrenoceptors in human and pig brain membranes. Hoyer D, Vos P, Closse A, Pazos A, Palacios JM, Davies H. Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar 16; 335(3):226-30. PubMed ID: 2884572 [Abstract] [Full Text] [Related]
18. [3H]ketanserin binds to non-5-HT2 sites in rabbit cerebral cortex and neostriatum. Dewar KM, Lima L, Reader TA. Neurochem Res; 1990 May 16; 15(5):507-14. PubMed ID: 2115148 [Abstract] [Full Text] [Related]
19. Synthesis and in vivo characterization of D-(+)-(N1-[11C]methyl)-2-Br-LSD: a radioligand for positron emission tomographic studies of serotonin 5-HT2 receptors. Lever JR, Dannals RF, Wilson AA, Ravert HT, Scheffel U, Hoffman BJ, Hartig PR, Wong DF, Wagner HN. Int J Rad Appl Instrum B; 1989 May 16; 16(7):697-704. PubMed ID: 2575605 [Abstract] [Full Text] [Related]
20. Differential effect of subchronic treatment with various neuroleptic agents on serotonin2 receptors in rat cerebral cortex. Andree TH, Mikuni M, Tong CY, Koenig JI, Meltzer HY. J Neurochem; 1986 Jan 16; 46(1):191-7. PubMed ID: 2866233 [Abstract] [Full Text] [Related] Page: [Next] [New Search]